References
- White WI. A new look at the role of urinalysis in the history of diagnostic medicine. Clin Chem. 1991;37(1):119–125. doi: 10.1093/clinchem/37.1.119
- Baldeh M, Bawa FK, Bawah FU, et al. Lessons from the pandemic: new best practices in selecting molecular diagnostics for point-of-care testing of infectious diseases in sub-saharan Africa. Expert Rev Mol Diagn. 2023;1–7. doi: 10.1080/14737159.2023.2277368
- Laryea ET, Nichols JH. Implementing individualized quality control plans and managing risk at the point-of-care for molecular diagnostics. Expert Rev Mol Diagn. 2023;1–7. doi: 10.1080/14737159.2023.2277374
- Rakeman-Cagno JL, Persing DH, Loeffelholz MJ. Maintaining point of care testing capacity and pandemic preparedness in the post-COVID-19 era. Expert Rev Mol Diagn. 2023;1–5. doi: 10.1080/14737159.2023.2260743
- Brown E, Hay AD. Point-of-care tests: the key to reducing antibiotic prescribing for respiratory tract infections in primary care? Expert Rev Mol Diagn. 2023;1–3. doi: 10.1080/14737159.2023.2217330
- Moerman A, De Waele JJ, Boelens J. An overview of point-of-care testing for infections in critically ill patients. Expert Rev Mol Diagn. 2024;1–8. doi: 10.1080/14737159.2024.2322146
- Milburn J, Suresh R, Doyle R, et al. The diagnosis of central nervous system infections in resource-limited settings and the use of novel and molecular diagnostic platforms to improve diagnosis. Expert Rev Mol Diagn. 2024;1–12. doi: 10.1080/14737159.2024.2317414
- Gradisteanu Pircalabioru G, Raileanu M, Dionisie MV, et al. Fast detection of bacterial gut pathogens on miniaturized devices: an overview. Expert Rev Mol Diagn. 2024;1–18. doi: 10.1080/14737159.2024.2316756
- Trubin P, Azar MM A fast-track to fungal diagnosis: the potential of molecular diagnostics for fungi at the point of care. Expert Rev Mol Diagn 2024;1–4. doi: 10.1080/14737159.2023.2287504
- Aerts R, Autier B, Gornicec M, et al. Point-of-care testing for viral-associated pulmonary aspergillosis. Expert Rev Mol Diagn. 2023;1–13. doi: 10.1080/14737159.2023.2257597
- Thornton CR. The potential for rapid antigen testing for mucormycosis in the context of COVID-19. Expert Rev Mol Diagn. 2023;1–7. doi: 10.1080/14737159.2023.2233906
- Grebely J, Matthews S, Causer LM, et al. We have reached single-visit testing, diagnosis, and treatment for hepatitis C infection, now what? Expert Rev Mol Diagn. 2024;1–15. doi: 10.1080/14737159.2023.2292645
- Spinelli M, Gandhi M. Point-of-care urine tenofovir monitoring of adherence to drive interventions for HIV treatment and prevention. Expert Rev Mol Diagn. 2024;1–7. doi: 10.1080/14737159.2024.2312122